THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, have long been a standard pharmacotherapy for patent ductus arteriosus (PDA). However, recently, paracetamol has also proven to produce the same effect by preventing prostaglandin synthesis. Several studies have compared the efficacy a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Lokot Donna Lubis
Formato: article
Lenguaje:EN
Publicado: Associazione Italiana Giovani Medici 2021
Materias:
Acceso en línea:https://doaj.org/article/5ac5cf6690364221b1fc0fb49ad3f9b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5ac5cf6690364221b1fc0fb49ad3f9b0
record_format dspace
spelling oai:doaj.org-article:5ac5cf6690364221b1fc0fb49ad3f9b02021-11-11T18:24:03ZTHE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS 10.3269/1970-5492.2021.16.292279-7165https://doaj.org/article/5ac5cf6690364221b1fc0fb49ad3f9b02021-11-01T00:00:00Zhttp://www.embj.org/wp-content/uploads/2021/11/Lubis_29.pdfhttps://doaj.org/toc/2279-7165Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, have long been a standard pharmacotherapy for patent ductus arteriosus (PDA). However, recently, paracetamol has also proven to produce the same effect by preventing prostaglandin synthesis. Several studies have compared the efficacy and side-effects of both drugs, but the results are not straightforward. The meta-analysis aims to compare the efficacy, side effects, and mortality of ibuprofen and paracetamol for treatment of PDA in preterm infants. Relevant articles were searched for on PubMed, Clinical Key, EMBASE, Cochrane Database, and Google Scholar before the study’s quality was assessed using the Jadad criteria and the data were analyzed using Review Manager. Fifteen clinical studies with 1477 preterm infants as the samples were analyzed using a meta-analysis. No significant statistical difference was found between the efficacy of paracetamol and ibuprofen in the DA closure and mortality cases. Meanwhile, for oliguria, kidney disease, and gastrointestinal bleeding, significant statistical difference was found with a lower risk in paracetamol. Lokot Donna LubisAssociazione Italiana Giovani Mediciarticleibuprofenparacetamolpatent ductus arteriosuspretermMedicine (General)R5-920ENEuromediterranean Biomedical Journal, Vol 16, Iss 29, Pp 124-130 (2021)
institution DOAJ
collection DOAJ
language EN
topic ibuprofen
paracetamol
patent ductus arteriosus
preterm
Medicine (General)
R5-920
spellingShingle ibuprofen
paracetamol
patent ductus arteriosus
preterm
Medicine (General)
R5-920
Lokot Donna Lubis
THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
description Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, have long been a standard pharmacotherapy for patent ductus arteriosus (PDA). However, recently, paracetamol has also proven to produce the same effect by preventing prostaglandin synthesis. Several studies have compared the efficacy and side-effects of both drugs, but the results are not straightforward. The meta-analysis aims to compare the efficacy, side effects, and mortality of ibuprofen and paracetamol for treatment of PDA in preterm infants. Relevant articles were searched for on PubMed, Clinical Key, EMBASE, Cochrane Database, and Google Scholar before the study’s quality was assessed using the Jadad criteria and the data were analyzed using Review Manager. Fifteen clinical studies with 1477 preterm infants as the samples were analyzed using a meta-analysis. No significant statistical difference was found between the efficacy of paracetamol and ibuprofen in the DA closure and mortality cases. Meanwhile, for oliguria, kidney disease, and gastrointestinal bleeding, significant statistical difference was found with a lower risk in paracetamol.
format article
author Lokot Donna Lubis
author_facet Lokot Donna Lubis
author_sort Lokot Donna Lubis
title THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_short THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_full THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_fullStr THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_full_unstemmed THE EFFICACY, SIDE-EFFECTS, AND MORTALITY COMPARISON BETWEEN PARACETAMOL AND IBUPROFEN IN PATENT DUCTUS ARTERIOSUS TREATMENT FOR PREMATURE INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
title_sort efficacy, side-effects, and mortality comparison between paracetamol and ibuprofen in patent ductus arteriosus treatment for premature infants: a systematic review and meta-analysis
publisher Associazione Italiana Giovani Medici
publishDate 2021
url https://doaj.org/article/5ac5cf6690364221b1fc0fb49ad3f9b0
work_keys_str_mv AT lokotdonnalubis theefficacysideeffectsandmortalitycomparisonbetweenparacetamolandibuprofeninpatentductusarteriosustreatmentforprematureinfantsasystematicreviewandmetaanalysis
AT lokotdonnalubis efficacysideeffectsandmortalitycomparisonbetweenparacetamolandibuprofeninpatentductusarteriosustreatmentforprematureinfantsasystematicreviewandmetaanalysis
_version_ 1718431824252764160